Lauren Chase Lauren Chase is on the Research Team at GoodRx. Posted on August 11, 2020 In an effort to continue to shed light on drug prices and increase transparency, the GoodRx Research Team regularly tracks the most expensive drugs in the U.S. Since 2018, we have tracked the list price and dosing requirements to...
by Elsevier A report in the Journal of Molecular Diagnostics describes a new and powerful laboratory tool that may improve the diagnosis and treatment of hepatitis B virus (HBV) infection. The technique can simultaneously assess several indicators important for optimal patient management. A team of scientists has developed a highly sensitive coamplification at lower denaturation temperature...
July 27, 2018, Westmead Institute for Medical Research A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection. First author Dr. Rasha El Sharkawy. Credit: The Westmead Institute for Medical Research Researchers from the Westmead Institute for Medical Research found that Caucasian...
Dr. Robert Lanford works in his lab at Texas Biomed. Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. Testing at SNPRC provided proof this novel therapeutic approach and drug...
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer...
Hepatitis B is notoriously difficult to eradicate with currently available agents.. Now, in a new study, a novel form of “pegylated” interferon-β has reduced hepatitis B virus (HBV) infections in experimental human-derived cells and in mice more effectively than the conventional pegylated interferon-α2a, suggesting that it could lead to improved treatment for hepatitis B infection in humans....
